Which of the following brought increased public attention to the problems with the IRB system?
The deaths of two research participants: Jesse Gelsinger, who died in a 1999 gene-therapy trial at the University of Pennsylvania, and Ellen Roche, a healthy volunteer who died in a 2001 asthma study at Johns Hopkins. Both cases exposed serious flaws in IRB oversight and prompted reform.
The answer
The events that brought increased public attention to the problems with the IRB (Institutional Review Board) system were the deaths of research subjects Jesse Gelsinger (1999) and Ellen Roche (2001). This is the standard answer in CITI Program research-ethics training. Both were high-profile tragedies at major research universities, and both revealed that IRB review, as practiced, was not reliably protecting human subjects.
Because these were preventable deaths of participants who had volunteered—one a young patient, one a healthy volunteer—they generated intense media coverage, federal investigations, and lasting changes to how research oversight works.
What happened in each case
Jesse Gelsinger (1999). An 18-year-old with a manageable metabolic disorder (OTC deficiency), Gelsinger enrolled in a gene-therapy trial at the University of Pennsylvania. He died from a massive immune reaction to the viral vector. Investigations found serious problems: he may not have met enrollment criteria, earlier adverse events in animals and other subjects had not been adequately reported, and the lead investigator and institution had financial conflicts of interest in the company developing the therapy. Consent and oversight failures were central.
Ellen Roche (2001). A healthy 24-year-old lab technician, Roche volunteered for an asthma study at Johns Hopkins that involved inhaling hexamethonium to provoke a physiological response. She developed progressive lung failure and died. Reviews found the consent form did not adequately convey the drug's risks, the substance was not approved for that use, and the investigator's literature search had missed known warnings about its toxicity—gaps the IRB had not caught.
Why the other options are wrong
On the CITI quiz, the distractors are usually earlier ethics scandals that predate or shaped the IRB system rather than exposing flaws within it:
- The Tuskegee Syphilis Study and the Nuremberg trials/Nazi experiments led to the creation of modern protections (the Nuremberg Code, the Belmont Report, and the Common Rule). They are foundational, but the question asks what drew renewed attention to problems with the IRB system already in place—that's Gelsinger and Roche.
- The Willowbrook or Beecher-era abuses similarly motivated the original establishment of IRBs.
- Routine regulatory updates did not, by themselves, generate the public scrutiny; the deaths did.
Gelsinger and Roche stand out because they happened after IRBs were well established, proving the system itself had gaps.
The bigger picture
These deaths triggered concrete reforms: temporary shutdowns of research at both institutions by federal regulators (the Office for Human Research Protections), tighter rules on conflict-of-interest disclosure, stronger adverse-event reporting, better informed-consent standards, and increased federal oversight of IRBs. They pushed research ethics beyond the historical scandals (Tuskegee, Nuremberg) that created the Common Rule, showing that oversight is a continuing responsibility, not a one-time fix. For anyone studying research ethics, the lesson is that IRBs must be actively resourced and monitored—paper compliance is not the same as real protection of human subjects.
- 1947
Nuremberg Code
Nazi medical-experiment trials produce the first modern code requiring voluntary informed consent—groundwork for later oversight.
- 1972
Tuskegee exposed
Public revelation of the 40-year Tuskegee Syphilis Study spurs U.S. reforms and the eventual creation of IRBs.
- 1979
Belmont Report
Establishes the principles (respect for persons, beneficence, justice) underpinning the IRB system and the Common Rule.
- 1999
Death of Jesse Gelsinger
An 18-year-old dies in a University of Pennsylvania gene-therapy trial; conflicts of interest and reporting failures draw national attention to IRB weaknesses.
- 2001
Death of Ellen Roche
A healthy volunteer dies in a Johns Hopkins asthma study; consent and safety-review gaps prompt federal research shutdowns and reforms.
Frequently asked
Who was Jesse Gelsinger?
Jesse Gelsinger was an 18-year-old who died in 1999 during a gene-therapy trial at the University of Pennsylvania. His death revealed enrollment, consent, adverse-event reporting, and financial conflict-of-interest failures, drawing national attention to weaknesses in the IRB system.
What happened to Ellen Roche in the Johns Hopkins study?
Ellen Roche was a healthy 24-year-old volunteer who died in 2001 after inhaling hexamethonium in a Johns Hopkins asthma study. The consent form understated the drug's risks and known toxicity warnings had been missed, exposing gaps in IRB oversight.
What is the purpose of an IRB?
An Institutional Review Board reviews and monitors research involving human subjects to protect their rights and welfare. It evaluates risks and benefits, informed consent, and safeguards before and during a study, applying the principles of the Belmont Report.
What reforms followed the Gelsinger case?
The case led to stricter conflict-of-interest disclosure rules, stronger adverse-event reporting requirements, improved informed-consent standards, and increased federal oversight of gene-therapy trials and IRBs by regulators such as the OHRP and FDA.
What is the Common Rule?
The Common Rule is the U.S. federal policy (45 CFR 46) governing the ethical conduct of research involving human subjects. It requires IRB review, informed consent, and protections for vulnerable populations across federally funded research.